EHA2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

EHA2024
Aug 2, 2024, 23:39 | Blog
The efficacy of BMA and the role of precision medicine in Myeloma
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jul 2, 2024, 08:18 | Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
Jun 30, 2024, 13:54 | Blog
Blood Cancers Today - Receiving ESAs before transfusions improved outcomes versus after transfusions in lower-risk MDS
Blood Cancers Today shared on X: "Among patients with anemia related to lower-risk MDS, receiving ESAs…
Jun 29, 2024, 04:01 | Opinion
Browse EHA2024 content on demand on the Congress Platform - European Hematology Association
European Hematology Association posted on X: “Did you miss a session in Madrid? Make sure…
Jun 27, 2024, 11:31 | Blog
Anna A. Avagyan: Unforgettable whirlwind of knowledge, connections, and cultural experiences
Anna A. Avagyan, Pediatric hematologist/oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia,…
Jun 26, 2024, 14:28 | Blog
Alexey Danilov on the treatment of R/R Follicular Lymphoma - The Video Journal of Hematology and Hematological Oncology
The Video Journal of Hematology and Hematological Oncology shared on X: "It was great to catch…
Jun 24, 2024, 02:19 | Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X:                   . "Delighted…
Jun 22, 2024, 12:17 | Blog
Dr. Yi Lin discusses the future of CART therapy at EHA2024
Abner Antonio Murray, Oncology Fellow at UNC School of Medicine, shared a post on X: "Exciting…
Jun 22, 2024, 09:53 | Blog
Podcasts with hematology experts from EHA2024
European Hematology Association shared a post on X: "Did you catch the EHA Unplugged team during…
Jun 21, 2024, 14:28 | Blog
Anna Avagyan: From first International Congress on Pediatric Oncology and Hematology to EHA2024
Anna Avagyan, Pediatric Hematologist/Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared…
Jun 21, 2024, 13:21 | Blog
Stellar talks from pioneering generation of haematologists at EHA2024 - Guezguez lab
Guezguez lab shared a post on X: “And it's a wrap for another fantastic European…
Jun 21, 2024, 12:25 | Blog
Sanam Loghavi: Another day in the life of a hematopathologist
Sanam Loghavi shared on X/Twitter: "Another day in the life of a hematopathologist….. To say I…
Jun 21, 2024, 09:47 | Blog
Blinatumomab alternating with LIC in older adults with newly diagnosed B-ALL - ALL Hub
ALL Hub shared a post on X: "CONGRESS | POSTER | EHA2024 | Elias Jabbour…
Jun 21, 2024, 08:22 | Blog
Amer Zeidan: Two additional studies from EHA2024 confirm validity of IWG2023
Amer Zeidan shared on X:               . "Two additional studies from…
Jun 21, 2024, 07:58 | Blog
Cancer Therapy Advisor - Results, from the STARGLO trial presented at EHA2024 by Dr Jeremy Abramson
Cancer Therapy Advisor shared a post on X: "Glofitamab plus GemOx improved outcomes over rituximab plus…
Jun 21, 2024, 05:59 | Blog
Results of ECHO study EHA
Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre,…
Jun 21, 2024, 05:21 | Blog
Mikkael A. Sekeres: The circle of academic hematology life
Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared…
Jun 20, 2024, 14:38 | Blog
Katherine Bridge: So welcomed into Young EHA's incredible community over the past 3 years
Katherine Bridge, Principal Investigator at University of York, posted on X: "EHA2024. I've been so…
Jun 20, 2024, 13:09 | Blog
Sophia Stock: Our work on immune reconstitution after CAR-T at EHA2024
Sophia Stock, Clinician Scientist at LMU Munich Hospital, shared a post on X: “Heading home…
Jun 20, 2024, 11:53 | Blog
Mohamad Mohty shares long-term survival outcomes from the phase II MagnetisMM-3 study - Multiple Myeloma Hub
Multiple Myeloma Hub shared on X/Twitter: "CONGRESS | POSTER | EHA2024 | Mohamad Mohty shares long-term…
Jun 20, 2024, 10:10 | Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 20, 2024, 03:53 | Insight
Gregorio Maria Bergonzi: EHA2024 has come to an end
Gregorio Maria Bergonzi, Hematology Resident at IRCCS San Raffaele Hospital, made the following post on…
Jun 19, 2024, 23:22 | Blog
Amer Zeidan: Looking forward to finding cures for all AML and MDS patients
Amer Zeidan shared on X: "Looking forward to finding cures for all Acute Myeloid Leukemia…
Jun 19, 2024, 23:16 | Societies
Uma Borate: And that’s a wrap for EHA 2024
Uma Borate, Acute Leukemia Translation Lead and Assistant Professor at OHSU, shared on X: "And…
Jun 19, 2024, 19:00 | Societies
Mandy Lauw: EHA2024 was a special Congress
Mandy Lauw, Internist-hematologist at Erasmus MC, shared a post on X: "EHA2024 was a special Congress!…
Jun 19, 2024, 15:08 | Blog
Always great to meet you, Michael Hallek - ESH
ESH (Haematology) shared a post by Michael Hallek, Director of Clinic I for Internal Medicine…
Jun 19, 2024, 07:45 | Insight
Graham Collins: Starglo - A practice changing study
Graham Collins, Associate Professor of Hematology at the Oxford Cancer and Hematology Center shared a…
Jun 18, 2024, 06:04 | Opinion
Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X: "Disappointing but important results from…
Jun 18, 2024, 04:43 | Blog
Ruben Mesa: Wonderful work by Nilanjan Ghosh at EHA2024
Ruben Mesa shared a post by Nilanjan Ghosh, Chair of Department of Hematologic Oncology and…
Jun 18, 2024, 03:30 | Blog
Ruben Mesa: Most active combination for MF to date
Ruben Mesa shared on LinkedIn: "Honored to be a Co-Investigator of important Pelabresib plus RUX 1L…
Jun 18, 2024, 02:37 | Blog
Amer Zeidan: A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes
Amer Zeidan shared a post on X: “A wonderful talk by Dr. Emma M. Groarke on…
Jun 17, 2024, 20:53 | Blog
Ruben Mesa: Making strides against Blood Cancers in the "Carolinas" and beyond
Ruben Mesa shared on LinkedIn: "Continued strong showing at EHA2024 from the amazing HemeTeam for our…
Jun 17, 2024, 20:29 | Blog
Elena Torre: Proud to be here as IACH Young Ambassador
Elena Torre, Honorary Clinical Fellow at Guy's and St Thomas'​ NHS Foundation Trust, shared a post…
Jun 17, 2024, 12:46 | Insight
Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the EHA 2024 - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center recently shared a post on X: "Our very own Dr. Antonio…
Jun 17, 2024, 07:05 | Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 17, 2024, 04:18 | Blog
Amer Zeidan: Amazing work by our fellows, 6 posters at EHA2024
Amer Zeidan shared on X/Twitter: "Amazing work by our fellows at Yale Hematology Oncology Fellows presenting…
Jun 17, 2024, 01:15 | Societies
Jean-Jacques Kiladjian: The new findings of Proud-Continuation PV randomized trial
Jean-Jacques Kiladjian, Professor of Clinical Pharmacology at Paris Diderot University, shared a post on X:…
Jun 16, 2024, 14:05 | Blog
Farina Arreguin: Germline predisposition of genetic testing in myeloid malignancies
Farina Arreguin, a Pediatric Oncologist at Star Medical Private Children’s Hospital, shared a post on…
Jun 16, 2024, 12:58 | Insight
Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X: "Encouraging to…
Jun 16, 2024, 02:39 | Blog
Andrius Žučenka: Stop by at our EHA2024 poster on relapsed/refractory AML
Andrius Žučenka, Head of The Department of Specialized Care For Immunocompromised Patients at VUL Santaros…
Jun 15, 2024, 14:51 | Blog
NCCN and NCCN Foundation are in Madrid for EHA2024
National Comprehensive Cancer Network (NCCN) shared on LinkedIn: “NCCN and NCCN Foundation are in Madrid,…
Jun 15, 2024, 14:14 | Blog
Aditi Shastri: Important updates from Amer Zeidan in myelodysplastic syndrome at EHA2024
Aditi Shastri, Associate Professor of Medicine at Einstein SCI, shared on X: “Come to the…
Jun 15, 2024, 12:41 | Blog
Naveen Pemmaraju: With MPN Guru and dear friend Prof Ruben Mesa at EHA2024
Naveen Pemmaraju recently shared a post on X: “Wonderful to be here at EHA2024 with MPN…
Jun 15, 2024, 09:46 | Blog
Amer Zeidan: Amazing work by our Yale Hematology Oncology Fellows at EHA2024
Amer Zeidan shared a post on X: “Amazing work by our Yale Hematology Oncology Fellows presenting…
Jun 15, 2024, 07:28 | Insight
Raul Cordoba: Welcome to EHA2024!
Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared…
Jun 15, 2024, 07:24 | Blog
Gregorio Maria Bergonzi: Excited to attend EHA2024
Gregorio Maria Bergonzi, Hematology Resident at IRCCS San Raffaele Hospital, made the following post on…
Jun 13, 2024, 05:46 | Societies
Carl Ola Landgren: Getting ready with Mohamad Mohty for tomorrow’s opening session at EHA2024
Carl Ola Landgren shared on X: "Getting ready together with Mohamad Mohty for tomorrow’s opening…
Jun 11, 2024, 16:35 | Blog
Kostas Tzelepis: Join me in Madrid for a fantastic EHA2024
Kostas Tzelepis, Principal Investigator at University of Cambridge, shared a post by European Hematology Association, on…
Jun 9, 2024, 16:53 | Blog
Raul Cordoba: Less than one week left until EHA2024 begins
Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared…
Jun 7, 2024, 14:27 | Blog
European School of Haematology will be at EHA2024!
The European School of Haematology (ESH) shared a post on X:      . "…
May 19, 2024, 18:09 | Societies
2 weeks left for EHA2024 regular registration - European Hematology Association
European Hematology Association recently shared on X: "2 weeks left for EHA2024 regular registration. Make…
May 18, 2024, 04:13 | Insight
Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024
Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X: “Look out for important…
May 17, 2024, 13:44 | Drugs
Rahul Banerjee: Analysis of carfilzomib dosing in R/R myeloma
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
May 13, 2024, 13:20 | Societies
EHA2024 is an opportunity for researchers to learn, connect, and grow - European Hematology Association
European Hematology Association shared on X:  “EHA2024 is an opportunity for researchers to learn, connect,…
May 5, 2024, 07:33 | Blog
2 days left to take advantage of the EHA2024 early-bird registration fee
European Haematology Association shared on X: “2 days left to take advantage of the EHA2024…
Feb 17, 2024, 10:49 | Blog
Raul Cordoba: Amazing progress done by scholars
Raul Cordoba, the Coordinator of the Lymphoma Unit at Jimenez Diaz Foundation University Hospital, Madrid,…
All: 56 Posts: 1 - 100
Special Coverage